Page last updated: 2024-10-29

ketamine and Neuroendocrine Tumors

ketamine has been researched along with Neuroendocrine Tumors in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Mielke, N1
Johnson, S1
Bahl, A1
Fadladdin, YAJ1
Xue, M1
Zhang, X1
Chen, J1
Liu, F1
Xu, J1
Xie, J1
Yang, Y1
Yu, W1
Qiu, H1
Xue, J1
Jiang, J1
Liu, Y2
Shallom, SJ1
Zelazny, AM1
Giri, AR1
Kaur, N1
Yarrarapu, SNS1
Rottman Pietrzak, KA1
Santos, C1
Lowman, PE1
Niaz, S1
Franco, PM1
Sanghavi, DK1
Zhu, D1
Liang, R1
Li, Z2
Cheng, L1
Ren, J1
Guo, Y1
Wang, M1
Chai, H1
Niu, Q1
Yang, S1
Bai, J1
Yu, H1
Zhang, H1
Qin, X1
Sahrakorpi, N1
Engberg, E1
Stach-Lempinen, B1
Tammelin, TH1
Kulmala, J1
Roine, RP1
Koivusalo, SB1
Cheng, W1
Pang, H1
Campen, MJ1
Zhang, J2
Li, Y1
Gao, J1
Ren, D1
Ji, X1
Rothman, N1
Lan, Q1
Zheng, Y1
Leng, S1
Hu, Z1
Tang, J1
Dong, Q1
Song, N1
Qin, N1
Chen, C1
Sun, X1
Easton, J1
Mulder, H1
Plyler, E1
Neale, G1
Walker, E1
Li, Q1
Ma, X1
Chen, X1
Huang, IC1
Yasui, Y1
Ness, KK1
Hudson, MM1
Robison, LL1
Wang, Z1
Subota, A1
Spotswood, N1
Roach, M1
Goodarzi, Z1
Holroyd-Leduc, J1
Park, EA1
Graves, SA1
Menda, Y1
Waldfogel, JM1
Nesbit, S1
Cohen, SP1
Dy, SM1

Reviews

1 review available for ketamine and Neuroendocrine Tumors

ArticleYear
    Lancet regional health. Americas, 2022, Volume: 8

    Topics: Adult; Aging; Aluminum; Alzheimer Disease; Animals; Anti-Bacterial Agents; Artemisia annua; Body Mas

2022

Other Studies

1 other study available for ketamine and Neuroendocrine Tumors

ArticleYear
Successful Treatment of Opioid-Refractory Cancer Pain with Short-Course, Low-Dose Ketamine.
    Journal of pain & palliative care pharmacotherapy, 2016, Volume: 30, Issue:4

    Topics: Adult; Analgesics; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Humans; Ketami

2016